Same-Day Chlamydia and Gonorrhea Testing for Campus Health Centers
College students fall within the age group that accounts for nearly half of all reported chlamydia, gonorrhea, and syphilis cases in the U.S.¹⁰. Send-out testing means lost follow-up over finals, breaks, and everything in between.
Same-Visit Testing. No Waiting for Students to Come Back.
The binx io is an FDA-cleared, CLIA-waived, molecular point-of-care platform for chlamydia (CT) and gonorrhea (NG), delivering PCR-accurate results in approximately 30 minutes with no laboratory or lab-trained staff required.1,2,3 For campus health centers, that means a positive result gets treated before a student is home for the weekend, gone for break, or simply hard to track down.
Lab Turnaround Times Are Costing You Patients
Send-out testing creates a multi-day window between testing and treatment, a window that lines up poorly with a student's schedule. Privacy concerns compound the timing problem: research on college testing barriers points to stigma and confidentiality fears, including worries about parents discovering a visit through insurance billing, as major reasons students avoid testing altogether.⁸ POC testing collapses that window to a single visit, directly improving treatment rates and reducing spread across campus.
- 2-3 days of processing time⁶ Patient likely gone before results return
- ~20% lost to follow-up⁴ Patients who never return for treatment or results
- Empiric antibiotic use Treatment decisions often made without confirmed diagnosis, undermining stewardship⁵
- Onward transmission risk Untreated patients continue spreading infection in the community
- ~30 minutes to result Same visit, same provider, same day
- In-visit test results Reducing patients who never return for treatment
- Targeted, confirmed treatment Diagnosis-driven prescribing supports antibiotic stewardship⁵
- Supports screening compliance Confirmed, in-clinic results count toward adolescent chlamydia screening measures⁷
Lab-Equivalent Accuracy in a Non-Lab Setting
| Chlamydia Sensitivity / Specificity | Gonorrhea Sensitivity / Specificity | |
|---|---|---|
| Female | 96.1% / 99.1% | 100.0% / 99.9% |
| Male | 92.5% / 99.3% | 97.3% / 100.0% |
It Fits Your Workflow
No lab staff, no certification, no complex setup. Fully automated with clear detected/not detected results, LIS/EMR integration, and an established reimbursement path for CT/NG point-of-care testing.
CLIA- Waived
No laboratory certification required. Any trained staff member can operate the instrument in a point-of-care setting.
Connectable
Ability to route directly into your existing systems. No manual transcription, no extra steps, no lag between result and clinical action.
Established reimbursement
CPT codes for CT/NG point-of-care testing are recognized by Medicare, Medicaid, and most commercial payers.Proven Acceptable to Students
In a study at a university student health clinic, 89.4% of students were willing to wait up to 20 minutes for a rapid CT/GC result, with an average of less than 11 minutes added to their visit and high satisfaction reported by both patients and staff.⁹Sources
1. Van Der Pol B, et al. Clinical Performance of the BD ProbeTec™ CT/GC Assay... [2,445-person multicenter study]. JAMA Network Open, 2020. https://doi.org/10.1001/jamanetworkopen.2020.4819 2. binx health io® CT/NG Assay Instructions for Use, MOB-ART-0700 v4.0, May 2022. 3. binx 510(k) Summary, K191352. https://www.accessdata.fda.gov/cdrh_docs/pdf19/K191352.pdf 4. Schwebke JR, Sadler R, Sutton JM, Hook EW 3rd. Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic. Sex Transm Dis 1997;24:181-184. https://pubmed.ncbi.nlm.nih.gov/9101628/ 6. Labcorp. Chlamydia/Gonococcus, NAA (Test 183194) — Result Turnaround Time. https://www.labcorp.com/tests/183194/chlamydia-gonococcus-naa 7. NCQA. Chlamydia Screening (CHL) — HEDIS Measure. https://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality-report/chlamydia-screening-chl/ (used on OBGYN page) 8. Reeves JM, Zigah EY, Shamrock OW, Khan D, Batten J, Abu-Ba'are GR, Nelson LE, Djiadeu P. Exploring Facilitators and Barriers to STD/STI/HIV Self-Testing Among College Students in the United States: A Scoping Review. J Prim Care Community Health. 2024;15:1-9. doi:10.1177/21501319241291758 9. Gettinger J, Van Wagoner N, Daniels B, Boutwell A, Van Der Pol B. Patients Are Willing to Wait for Rapid Sexually Transmitted Infection Results in a University Student Health Clinic. Sex Transm Dis. 2020;47(1):67-69. doi:10.1097/OLQ.0000000000001083 10. Centers for Disease Control and Prevention. National Overview of STIs in 2023. https://www.cdc.gov/sti-statistics/annual/summary.html
